NCT06747234View on ClinicalTrials.gov

Oat Bran and Plasma Lipid and Fecal Bacteria in Coronary Artery Disease Patients

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

May 20, 2025

Primary Completion Date

September 2, 2025

Study Completion Date

October 6, 2025

Conditions
Coronary Arterial Disease (CAD)
Interventions
OTHER

Oat bran group

Patients consume 28 grams of oat bran daily for two months in addition to their usual medical treatment.

OTHER

Control (Standard treatment)

Patients receive standard medical treatment.

Trial Locations (2)

Unknown

RECRUITING

Shahid Modaress Hospital, Tehran

NOT_YET_RECRUITING

Shahid Modarres Hospital, Tehran

All Listed Sponsors
lead

Shahid Beheshti University of Medical Sciences

OTHER